Clinical Rheumatology

, Volume 27, Issue 6, pp 685–688 | Cite as

The use of bisphosphonate in the treatment of avascular necrosis: a systematic review

  • Juliana Bahia Cardozo
  • Débora Motta S. Andrade
  • Mittermayer B. Santiago
Review Article

Abstract

Up to now, there is no uniformly accepted treatment for avascular necrosis (AN) that alleviates pain and retards its progression. The aim of clinical and surgical treatments is usually only to improve blood support in the avascular area. The objective of the present study was to make a systematic review of the use of bisphosphonates in the treatment of AN. Studies in which bisphosphonate was used for the treatment of AN were researched through the MEDLINE databases (from 1966 to 2007) and the Cochrane Central Register of Controlled Trials and using the following terms: “avascular necrosis,” “aseptic necrosis,” “bisphosphonates,” “alendronate,” “pamidronate,” “zoledronate,” and “risedronate”. Only seven articles that met the previously established criteria were obtained from MEDLINE, and none were obtained from the Cochrane Central Register of Controlled Trials. Of these seven articles, two were randomized clinical trials and five were prospective comparative studies; one of them corresponded to an extension of a previous study. The present review demonstrates that there are no controlled and double-blind studies about the efficacy of bisphosphonates in the treatment of AN. Therefore, the data are still insufficient for justifying its use for this indication. On the other hand, noncontrolled studies appear to demonstrate favorable results, particularly in diminishing pain, improving mobility, and lowering the incidence of articular collapse, which justifies new studies being developed in this area.

Keywords

Alendronate Aseptic necrosis Avascular necrosis Bisphosphonates Pamidronate Risedronate Zoledronate 

References

  1. 1.
    Agarwala S, Jain D, Joshi VR, Sule A (2005) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford) 44(3):352–359CrossRefGoogle Scholar
  2. 2.
    Nishii T, Sugano N, Ohzono K, Sakai T, Haraguchi K, Yoshikawa H (2002) Progression and cessation of collapse in osteonecrosis of the femoral head. Clin Orthop Relat Res(400):149–157PubMedCrossRefGoogle Scholar
  3. 3.
    Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 87(10):2155–2159PubMedCrossRefGoogle Scholar
  4. 4.
    Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H (2006) Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 443:273–279PubMedCrossRefGoogle Scholar
  5. 5.
    Agarwala S, Sule A, Pai BU, Joshi VR (2002) Alendronate in the treatment of avascular necrosis of the hip. Rheumatology (Oxford) 41(3):346–347CrossRefGoogle Scholar
  6. 6.
    Ramachandran M, Ward K, Brown RR, Munns CF, Cowell CT, Little DG (2007) Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. J Bone Joint Surg Am 89(8):1727–1734PubMedCrossRefGoogle Scholar
  7. 7.
    Nguyen T, Zacharin MR (2006) Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukemia—two-year outcomes. J Pediatr Endocrinol Metab 19(2):161–167PubMedGoogle Scholar
  8. 8.
    Wang CJ, Wang FS, Yang KD, Huang CC, Lee MS, Chan YS et al (2008) Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate. Arch Orthop Trauma Surg DOI 10.1007/s00402-007-0530-5
  9. 9.
    Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH (1995) Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br 77(6):870–874PubMedGoogle Scholar
  10. 10.
    Little DG, Peat RA, Mcevoy A, Williams PR, Smith EJ, Baldock PA (2003) Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 18(11):2016–2022PubMedCrossRefGoogle Scholar
  11. 11.
    Kim HK, Randall TS, Bian H, Jenkins J, Garces A, Bauss F (2005) Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 87(3):550–557PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2008

Authors and Affiliations

  • Juliana Bahia Cardozo
    • 1
  • Débora Motta S. Andrade
    • 1
  • Mittermayer B. Santiago
    • 2
  1. 1.Serviço de Reumatologia do Hospital Santa Izabel (HSI)SalvadorBrazil
  2. 2.Serviço de Reumatologia (HSI)Escola Bahiana de Medicina e Saúde PúblicaSalvadorBrazil

Personalised recommendations